| URL | https://www.pressherald.com/2021/12/22/covid-19-ho |
| Source | https://www.pressherald.com/ |
| Date Published | 12/22/2021 |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Abbott |
| Parent company | Abbott |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| What product(s) and/or service(s) were outsourced domestically? | Manufacturing |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2021 |
| Domestically, the work will be done: | In-house |
| City reshored to: | Chicago |
| State(s) reshored to: | IL |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | COVID-19 home test, rapid test |